IHS Chemical Week

Chemical Week Magazine :: Business & Finance :: Europe/Mideast

DSM Sets Ambitious Targets, Divests Citric Acid Business

8:52 AM MDT | September 24, 2010 | Natasha Alperowicz

DSM (Heerlen, the Netherlands) has updated financial targets to include sharply higher Ebitda and higher return on capital. The company also announced the sale of its citric acid business to Adcuram (Munich) and the formation of a joint venture with DuPont in surgical biomedical materials. DSM also plans to expand its biopharmaceutical joint venture with Crucell and is seeking partnerships for its anti-infectives business with companies in China and India. The company has set an Ebitda target of €1.4 billion-€1.6 billion ($1.9 billion-$2.1 billion) and return...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa